Trade Mark Journal No.2026/008 20 February 2026

UK00004336829 6 February 2026 (1)

THERAPEAK ACTICELL

International priority date claimed: 6 February 2026 (European Union Intellectual Property Office (EUIPO)) (019313799)

Class 1: Diagnostic biochemical and chemical preparations for use in laboratory research; biochemical and chemical reagents for scientific laboratory use; diagnostic reagents for scientific use; laboratory reagents for scientific use; screening kits for scientific laboratory and scientific use consisting primarily of assay and detection reagents.

Lonza Walkersville, Inc.

Representative: Simkins LLP